[Consumption of adrenaline and hepatic glycogenolysis before and after monoamine oxidase (MAO) and catechol-O-methyltransferase block].
V G
VG
FOGLIA
A E
AE
DOMINGUEZ
J C
JC
RAMASSO
D050260:Carbohydrate Metabolism; D002241:Carbohydrates; D002394:Catechol O-Methyltransferase; D004837:Epinephrine / Q000378:metabolism*; D050261:Glycogenolysis; D008099:Liver / Q000378:metabolism*; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D011748:Pyrogallol / Q000494:pharmacology*
D002241:Carbohydrates; D008996:Monoamine Oxidase Inhibitors; D011748:Pyrogallol; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D004837:Epinephrine
CARBOHYDRATES/metabolism; EPINEPHRINE/metabolism; LIVER/metabolism; MONOAMINE OXIDASE INHIBITORS/pharmacology; PYROGALLOL/pharmacology